DocMeetings

Day 1 – 13 November 2020

12:40 – 12:45 Welcome and Introduction Virtual Room 1

Medical oncologist - Aristotelis Bamias, Athens (GR)

Radiation oncologist - Peter Hoskin, Northwood (GB)

Urologist - Arnulf Stenzl, Tübingen (DE)

12:45 – 13:30 Individualised approaches in advanced prostate cancer

Chairs: Medical oncologist - Jan Oldenburg, Oslo (NO)

Radiation oncologist - Thomas Zilli, Geneva (CH)

Urologist - Jochen Walz, Marseille (FR)

12:45 – 12:55 Germline mutation testing: When and how?

Medical oncologist - Johann De Bono, Sutton (GB)

12:55 – 13:05 PSMA PET for upfront staging in high risk disease?

Urologist - Declan Murphy, Melbourne (AU)

13:05 – 13:15 Who is the optimal candidate for treatment of the primary tumour in oligometastatic disease?

Radiation oncologist - Piet Ost, Ghent (BE)

13:15 – 13:30 Discussion

13:30 – 13:45 Industry presentation Virtual Room 1

13:45 – 14:30 Metastatic prostate cancer Virtual Room 2

Chairs: Radiation oncologist - Peter Hoskin, Northwood (GB)

Medical oncologist - Silke Gillessen, Bellinzona (CH)

Urologist - Hein Van Poppel, Leuven (BE)

Multidisciplinary case discussion: Metachronous metastatic prostate cancer

Case presenter: Urologist - Giorgio Gandaglia, Milan (IT)

Case discussants: Medical oncologist - Silke Gillessen, Bellinzona (CH)

Pathologist - Antonio Lopez-Beltran, Lisbon (PT)

Radiation oncologist - Gert De Meerleer, Leuven (BE)

Radiologist - Raymond Oyen, Leuven (BE)

Urologist - Markus Graefen, Hamburg (DE)

14:30 – 14:45 Industry presentation Virtual Room 2

14:45 – 15:30 Highlights in GU cancers Virtual Room 1

Chairs: Medical oncologist – Stephane Oudard, Paris (FR)

Pathologist - Rodolfo Montironi, Ancona (IT)

Urologist - Morgan Rouprêt, Paris (FR)

14:45 – 14:55 ESUP lecture: Highlights from the Genito-Urinary Pathology Society (GUPS)

Pathologist - Jonathan Epstein, Baltimore (US)

14:55 – 15:05 The EAU research foundation: Trials in progress

Urologist - Anders Bjartell, Malmö (SE)

15:05 - 15:15 Highlights in Europa Uomo Patient Reported Outcomes Study (EUPROMS)

Patient Advocate – André Deschamps, Antwerp (BE)

15:15 – 15:30 Discussion

15:30 – 15:45 Industry presentation Virtual Room 1

15:45 – 16:30 Refining the treatment of bladder cancer Virtual Room 2

Chairs: Medical oncologist - Andrea Necchi, Milan (IT)

Pathologist - Eva Compérat, Paris (FR)

Urologist - George Thalmann, Berne (CH)

15:45 – 15:55 Novel options for the treatment of high risk non-muscle bladder cancer

Urologist - Marc-Oliver Grimm, Jena (DE)

15:55 – 16:05 Molecular sub-staging: Is it really useful?

Urologist - Peter Black, Vancouver (CA)

16:05 – 16:15 Optimal first line therapy in metastatic disease

Medical oncologist - Matthew Galsky, New York (US)

16:15 – 16:30 Discussion

16:30 – 17:15 Industry session Janssen Virtual Room 1

17:15 – 18:00 Round table on the Impact of COVID-19 epidemic on the management of GU cancers Virtual Room 2

Chairs: Medical oncologist - Aristotelis Bamias, Athens (GR)

Radiation oncologist - Carl Salembier, Brussels (BE)

Urologist - Arnulf Stenzl, Tübingen (DE)

17:15 – 17:25 Does the Corona infection interfere with immune status of oncological patients?

Virologist - TBC

17:25 – 17:35 Impact on COVID-19 on treatments of GU cancers

Urologist - Christopher Wallis, Nashville (US)

17:35 – 17:45 Indications from the EAU Guidelines Office Rapid Reaction Group (GORRG)

Urologist - Maria Ribal, Barcelona (ES)

17:45 – 18:00 Discussion

18:00 – 18:45 Industry session Virtual Room 1

18:45 – 19:30 New trials update

Chairs: Medical oncologist - Silke Gillessen, Bellinzona (CH)

Radiation oncologist - Jean Emmanuel Bibault, Paris (FR)

Urologist - Bertrand Tombal, Brussels (BE)

18:45 – 19:00 PROFOUND

Speaker: Medical oncologist - Maha Hussain, Ann Arbor (US)

Discussant: Medical oncologist – Henrik Gronberg, Stockholm (SW)

19:00 – 19:15 NIMBUS Trial

Speaker: Urologist - Marc Oliver Grimm, Jena (DE)

Discussant: Urologist - Axel Merseburger, Lübeck (DE)

19:15 – 19:30 DANUBE Trial

Speaker: Medical oncologist - Thomas Powles, London (GB)

Discussant: Medical oncologist - Andrea Necchi, Milan (IT)

19:30 – 20:15 Multidisciplinary case discussion on kidney cancer Virtual Room 2

Chairs: Medical oncologist - Laurence Albiges, Villejuif (FR)

Pathologist - TBC

Urologist - Igle Jan De Jong, Groningen (NL)

Radiation oncologist - Michael Pinkawa, Bonn (DE)

19:30 – 20:15 Intermediate risk metastatic renal cell cancer

Case presenter: Urologist - Carme Mir, Barcelona (ES)

Discussants: Urologist - Axel Bex, London (GB)

Urologist - Michael Staehler, Munich (DE)

Medical oncologist - Laurence Albiges, Villejuif (FR)

Medical oncologist - Camillo Porta, Bari (IT)

Radiation oncologist - Michael Pinkawa, Bonn (DE)